Literatur
-
1
Anderson D R, Harrison L, Hirsh J.
Evaluation of a portable prothrombin time
monitor for home use by patients who require long-term oral anticoagulant
therapy.
Arch Intern Med.
1993;
153
1441-1447
-
2
Ansell J, Hirsh J, Hylek E, Jacobson A. et al .
Pharmacology and management of
the vitamin K antagonists: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest.
2008;
133
160S-198
-
3
Ansell J E, Patel N, Ostrovsky D. et al .
Long-term patient self-management of oral
anticoagulation.
Arch Intern Med.
1995;
155
2185-2189
-
4
Bereznicki L R, Jackson S L, Peterson G M. et al .
Accuracy and clinical utility
of the CoaguChek® XS portable international normalised
ratio monitor in a pilot study of warfarin home-monitoring.
J
Clin Pathol.
2007;
60
311-314
-
5 Bernardo A, Taborski U, Wittstamm F J. Arbeitsgemeinschaft Selbstkontrolle der
Antikoagulation: Standards und Informationen. URL: http://www.asaev.de [Stand:
13.05.2008].
-
6
Bernardo A, Voller H. Arbeitsgemeinschaft Selbstkontrolle
der Antikoagulation A .
Leitlinie „Gerinnungsselbstmanagement”.
Dtsch Med Wochenschr.
2001;
126
346-351
-
7
Beyth R J, Quinn L, Landefeld C S.
A Multicomponent intervention to prevent major bleeding complications
in older patients receiving warfarin: a randomized, controlled trial.
Ann Intern Med.
2000;
133
687-695
-
8
Biasiolo A, Rampazzo P, Furnari O. et al .
Comparison between routine laboratory prothrombin
time measurements and fingerstick determinations using a near-patient
testing device (Pro-Time(R)).
Thromb Res.
2000;
97
495-498
-
9
Bodin L, Verstuyft C, Tregouet D A. et al .
Cytochrome P450 2C9 (CYP2C9) and vitamin
K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol
sensitivity.
Blood.
2005;
106
135-140
-
10
Braun S, Watzke H, Hasenkam J M. et al .
Performance evaluation of the new CoaguChek® XS
system compared with the established CoaguChek® system
by patients experienced in INR-self management.
Thrombosis
Haemost.
2007;
97
310-314
-
11
Braun S L, Soppa C, Taborski U, Völler H.
Qualitätssicherung
der Patientenschulung zur Selbstkontrolle der Antikoagulation.
Z ärztl Fortbild Qual Gesundhwes.
2007;
101
194-195
-
12
Bundesministerium der Justiz .
Bekanntmachung der Spitzenverbände der Krankenkassen – Fortschreibung
des Hilfsmittelverzeichnisses. Produktgruppe 21 „Messgeräte
für Körperzustände/-funktionen”.
Bundesanzeiger.
2002;
54
18805
-
13
Christensen T D, Johnsen S P, Hjortdal V E, Hasenkam J M.
Self-management of
oral anticoagulant therapy: A systematic review and meta-analysis.
Int J Cardiol.
2007;
118
54-61
-
14
Cromheecke M E, Levi M, Colly L P. et al .
Oral anticoagulation self-management and
management by a specialist anticoagulation clinic: a randomised
cross-over comparison.
Lancet.
2000;
356
97-102
-
15
Dorfman D M, Goonan E M, Boutilier M K. et al .
Point-of-care (POC) versus central
laboratory instrumentation for monitoring oral anticoagulation.
Vasc Med.
2005;
10
23-27
-
16
Douketis J D, Lane A, Milne J. et
al .
Accuracy of a portable International Normalization
Ratio monitor in outpatients receiving long-term oral anticoagulant
therapy: comparison with a laboratory reference standard using clinically
relevant criteria for agreement.
Thromb Res.
1998;
92
11-17
-
17
Fitzmaurice D A, Murray E T, Gee K M. et al .
A randomised controlled
trial of patient self management of oral anticoagulation treatment
compared with primary care management.
J Clin Pathol.
2002;
55
845-849
-
18
Gadisseur A PA, Kaptein A A, Breukink-Engbers W GM. et al .
Patient self-management
of oral anticoagulant care vs. management by specialized anticoagulation
clinics: positive effects on quality of life.
J Thromb
Haemost.
2004;
2
584-591
-
19
Hasenkam J M, Kimose H H, Knudsen L. et al .
Self management of oral anticoagulant therapy
after heart valve replacement.
Europ J Cardiothorac Surg.
1997;
11
935-942
-
20
Heidinger K S, Bernardo A, Taborski U, Muller-Berghaus G.
Clinical outcome of
self-management of oral anticoagulation in patients with atrial
fibrillation or deep vein thrombosis.
Thromb Res.
2000;
98
287-293
-
21
Heneghan C, Alonso-Coello P, Garcia-Alamino J. et al .
Self-monitoring of oral anticoagulation:
a systematic review and meta-analysis.
Lancet.
2006;
367
404-411
-
22
Horstkotte D, Piper C, Wiemer M.
Optimal Frequency of Patient Monitoring and Intensity of Oral
Anticoagulation Therapy in Valvular Heart Disease.
J Thromb
Thrombolys.
1998;
5
19-24
-
23 ISO .Clinical laboratory testing and in vitro diagnostic test systems – Requirements
for in vitro monitoring systems for self-testing of oral anticoagulant
therapy. In: ISO International Organization for
Standardization. 2003: 38
-
24
Koertke H, Minami K, Bairaktaris A. et al .
INR self-management following mechanical
heart valve replacement.
J Thromb Thrombolys.
2000;
9
S41-S45
-
25
Koertke H, Zittermann A, Tenderich G. et al .
Low-dose oral anticoagulation in patients
with mechanical heart valve prostheses: final report from the early
self-management anticoagulation trial II.
Eur Heart J.
2007;
28
2479-84
-
26
Kortke H, Korfer R.
International normalized
ratio self-management after mechanical heart valve replacement:
is an early start advantageous?.
Ann Thorac Surg.
2001;
72
44-48
-
27
Lafata J E, Martin S A, Kaatz S, Ward R E.
The cost-effectiveness
of different management strategies for patients on chronic warfarin
therapy.
J Gen Intern Med.
2000;
15
31-37
-
28
Leichsenring I, Plesch W, Unkrig V. et al .
Multicentre ISI assignment and calibration
of the INR measuring range of a new point-of-care system designed
for home monitoring of oral anticoagulation therapy.
Thromb
Haemost.
2007;
97
856-861
-
29
Menendez-Jandula B, Souto J C, Oliver A. et al .
Comparing Self-Management of Oral Anticoagulant
Therapy with Clinic Management: A Randomized Trial.
Ann
Intern Med.
2005;
142
1-10
-
30
Müller-Beißenhirtz W, Deickert F, Lang H. et al .
Selbstkontrolle der oralen Antikoagulation:
Standortbestimmung.
J Lab Med.
1997;
21
558-562
-
31
Newall F, Bauman M.
Point-of-care antithrombotic
monitoring in children.
Thromb Res.
2006;
118
113-121
-
32
Newall F, Monagle P, Johnston L.
Home INR monitoring of oral anticoagulant therapy in children
using the CoaguChek(TM) S point-of-care monitor and a robust education
program.
Thromb Res.
2006;
118
587-593
-
33
Piso B, Jimenz-Boj E, Krinninger B, Watzke H H.
The quality
of oral anticoagulation before, during and after a period of patient
self-management.
Thromb Res.
2002;
106
101-104
-
34
Rost S, Fregin A, Ivaskevicius V. et al .
Mutations in VKORC1 cause warfarin resistance
and multiple coagulation factor deficiency type 2.
Nature.
2004;
427
537-541
-
35
Sawicki P T.
A structured teaching and self-management program for patients
receiving oral anticoagulation: a randomized controlled trial. Working
Group for the Study of Patient Self-Management of Oral Anticoagulation.
JAMA.
1999;
281
145-150
-
36
Sidhu P, O’Kane H O.
Self-managed
anticoagulation: results from a two-year prospective randomized
trial with heart valve patients.
Ann Thorac Surg.
2001;
72
1523-1527
-
37
Siebenhofer A, Rakovac I, Kleespies C. et al .
Self-management of oral anticoagulation
in the elderly: Rationale, design, baselines and oral anticoagulation
control after one year of follow-up.
Thromb Haemost.
2007;
97
408-416
-
38
Sunderji R, Gin K, Shalansky K. et al .
A randomized trial of patient self-managed
versus physician-managed oral anticoagulation.
Can J Cardiol.
2004;
20
1117-1123
-
39
Taborski U, Braun S L, Völler H.
Analytical Performance of the New Coagulation
Monitoring System INRatio™ for the Determination of INR
Compared with the Coagulation Monitor Coaguchek® S and
an Established Laboratory Method.
J Thromb Thrombolys.
2004;
18
103-107
-
40
Taborski U, Wittstamm F J, Bernardo A.
Cost-effectiveness of self-managed anticoagulant
therapy in Germany.
Semin Thromb Hemost.
1999;
25
103-107
-
41
van den Besselaar A M, Breddin K, Lutze G. et al .
Multicenter evaluation of
a new capillary blood prothrombin time monitoring system.
Blood
Coagula Fibrinolysis.
1995;
6
726-732
-
42
van den Besselaar A M, Meeuwisse-Braun J. et
al .
A comparison between capillary and venous blood
international normalized ratio determinations in a portable prothrombin
time device.
Blood Coagul Fibrinolysis.
2000;
11
559-562
-
43
van den Besselaar A M.
Accuracy, precision, and quality control
for point-of-care testing of oral anticoagulation.
J Thromb
Thrombolys.
2001;
12
35-40
-
44
Voeller H, Dovifat C, Glatz J. et al .
Self management of oral anticoagulation with
the IN Ratio system: impact of a structured teaching program on
patient’s knowledge of medical background and procedures.
Eur J Cardiovasc Prev Rehabil.
2004;
11
442-447
-
45
Voeller H, Dovifat C, Wegscheider K.
Experience with INR self-management: patient selection and complication
rates.
Z Kardiol.
2005;
94
801-7
-
46
Völler H, Glatz J, Taborski U. et al .
Self-Management of oral Anticoagulation in
nonvalvular Atrial Fibrillation (SMAAF study).
Z Kardiol.
2005;
94
182-186
-
47
Völler H, Taborski U, Dovifat C. et al .
ProTime® self-management yielding improvement
of fluency and quality of life.
Thromb Haemost.
2007;
98
889-95
-
48
Watzke H H, Forberg E, Svolba G. et al .
A prospective controlled trial comparing
weekly self-testing and self-dosing with the standard management of
patients on stable oral anticoagulation.
Thromb Haemost.
2000;
83
661-665
-
49
White R H, McCurdy S A, von Marensdorff H. et al .
Home prothrombin time monitoring
after the initiation of warfarin therapy. A randomized, prospective
study.
Ann Intern Med.
1989;
111
730-737
Prof. Dr. med. Heinz Völler
FESC, Klinik am See, Klinik für
Herz- und Kreislauferkrankungen
Seebad 84
15562 Rüdersdorf
Phone: 033638/78-623
Fax: 033638/78-624
Email: heinz.voeller@klinikamsee.com
